Zacks Investment Research
15 Sept 2025, 14:56 UTC · 51w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
Pyxis Oncology (PYXS) has formed a 'golden cross' technical pattern, where its 50-day moving average crossed above its 200-day moving average. — A golden cross is a widely watched bullish indicator that often triggers increased buying pressure and momentum.
+0.40Earnings estimates for Pyxis Oncology (PYXS) have seen three upward revisions and no downward revisions over the last two months. — Positive revisions to analyst consensus typically suggest improving fundamentals and a higher likelihood of an earnings beat.
+0.30Pyxis Oncology (PYXS) currently holds a Zacks Rank #2 (Buy). — A 'Buy' rating from a major research provider provides a positive signal to retail and institutional investors.
+0.20Which stocks this story touches
Continue reading
5 related stories
Search tags
The company shows a bullish 'golden cross' technical pattern, a #2 Buy rank, and positive earnings estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
11h ago
